Skip to main content
. 2018 May 4;9(34):23366–23372. doi: 10.18632/oncotarget.25163

Figure 2. Kaplan–Meier analysis of relapse free survival and overall survival based on the presence of CD8, CD45RO or CD8CD45RO tumor infiltrating lymphocytes.

Figure 2